FDA Label for Lamotrigine
View Indications, Usage & Precautions
Lamotrigine Product Label
The following document was submitted to the FDA by the labeler of this product Zydus Lifesciences Limited. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Package Label.Principal Display Panel
NDC 70771-1514-3
Lamotrigine extended-release tablets, 25 mg
Rx only
30 tablets
NDC 70771-1515-3
Lamotrigine extended-release tablets, 50 mg
Rx only
30 tablets
NDC 70771-1516-3
Lamotrigine extended-release tablets, 100 mg
Rx only
30 tablets
NDC 70771-1517-3
Lamotrigine extended-release tablets, 200 mg
Rx only
30 tablets
NDC 70771-1518-3
Lamotrigine extended-release tablets, 250 mg
Rx only
30 tablets
NDC 70771-1519-3
Lamotrigine extended-release tablets, 300 mg
Rx only
30 tablets
* Please review the disclaimer below.